The role of miR-146a and IL-17 in the progression of primary biliary cholangitis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900021486

Enrollment

Unknown

Registered

2019-02-23

Start date

2019-03-01

Completion date

Unknown

Last updated

2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary biliary cholangitis

Interventions

Primary biliary cholangitis patients:none

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Primary biliary cholangitis; Aged 18~65 years.

Exclusion criteria

Exclusion criteria: 1. Liver diseases caused by other causes, such as viral hepatitis, alcoholic liver, fatty liver, drug-induced liver, etc.; 2. Rheumatic immune diseases, such as Sjogren's syndrome, rheumatoid arthritis, etc.; 3. Diabetes, coronary heart disease, thyroid disease, kidney disease, biliary tract stones, other malignant tumors; 4. Other factors that can not be identified Leading to abnormal liver function.

Design outcomes

Primary

Measure	Time frame
miR-146a;IL-17;	—

Countries

China

Contacts

Public ContactMeixin Ren

Beijing YouAn Hospital, Capital Medical University

rmx-306@126.com+86 13810210086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026